Dongwha Pharm.Co.Ltd (000020) — Free Cash Flow Generation Index
Dongwha Pharm.Co.Ltd (000020) has a Free Cash Flow Generation Index of -4.32x as of March 2026. Free cash flow of ₩-3.01 Billion represents -4% of operating cash flow (₩697.02 Million). Read 000020 total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Dongwha Pharm.Co.Ltd Free Cash Flow Generation Index (2011–2025)
Historical FCF Generation Index trend for Dongwha Pharm.Co.Ltd across 12 annual periods. Explore Dongwha Pharm.Co.Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year Free Cash Flow Generation Index for Dongwha Pharm.Co.Ltd. For the full company profile including market capitalisation, see 000020 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.52x | ₩-39.60 Billion | ₩15.70 Billion | ₩55.30 Billion | ▼ -2708.0% |
| 2023 | 0.10x | ₩2.82 Billion | ₩29.17 Billion | ₩26.35 Billion | ▼ -69.0% |
| 2022 | 0.31x | ₩9.13 Billion | ₩29.22 Billion | ₩18.43 Billion | ▲ +0.0% |
| 2021 | 0.31x | ₩11.26 Billion | ₩36.03 Billion | ₩21.94 Billion | ▼ -26.2% |
| 2020 | 0.42x | ₩22.11 Billion | ₩52.23 Billion | ₩34.25 Billion | ▼ -27.7% |
| 2019 | 0.59x | ₩7.78 Billion | ₩13.28 Billion | ₩4.80 Billion | ▼ -46.7% |
| 2016 | 1.10x | ₩27.99 Billion | ₩25.48 Billion | ₩2.50 Billion | ▲ +5.1% |
| 2015 | 1.04x | ₩20.72 Billion | ₩19.83 Billion | ₩885.50 Million | ▼ -4.5% |
| 2014 | 1.09x | ₩14.79 Billion | ₩13.51 Billion | ₩1.28 Billion | ▼ -21.6% |
| 2013 | 1.40x | ₩11.45 Billion | ₩8.21 Billion | ₩3.24 Billion | ▲ +11.0% |
| 2012 | 1.26x | ₩31.71 Billion | ₩25.23 Billion | ₩6.48 Billion | ▲ +4.9% |
| 2011 | 1.20x | ₩55.39 Billion | ₩46.24 Billion | ₩9.15 Billion | — |